Methods of treating cancer by administering antibodies to CD200
Number of patents in Portfolio can not be more than 2000
United States of America Patent
Stats
-
Feb 15, 2011
Grant Date -
Feb 26, 2009
app pub date -
Oct 7, 2008
filing date -
Nov 7, 1997
priority date (Note) -
Expired
status (Latency Note)
Importance
Abstract
Methods and compositions for regulating immunity are disclosed. For enhancing an immune response, agents that inhibit OX-2 are administered. Such methods are useful in treating cancer. For suppressing an immune response, an OX-2 protein or a nucleic acid encoding an OX-2 protein is administered. Such methods are useful in preventing graft rejection, fetal loss, autoimmune disease, allergies and in inducing tumor cell growth.
First Claim
Family
International Classification(s)
Cited Art Landscape
Patent Citation Ranking
Recipient Email Address
Recipient Email Address
Comment
Recipient Email Address
Add to Portfolio(s)
To add this patent to one, or more, of your portfolios, simply click the add button.
This Patent is in these Portfolios:
Add to additional portfolios:
Last Refreshed On:
Changes done successfully